← Eichor
Condition: Esophagogastric Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Esophagogastric Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Phase 2 · 1 location(s) · Dallas VA Medical Center · NCT04018872Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)
NA · 1 location(s) · University Health Network, Toronto · NCT06668454Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer
Phase 2 · 1 location(s) · Ruijin Hospital · NCT07026149Proton Therapy for Esophageal Cancer
NA · 1 location(s) · Loma Linda University · NCT01684904Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
Phase 2 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06510010Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction
Phase 2 · 10 location(s) · Erasmus Medical Center · NCT06161818A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique
NA · 1 location(s) · Huashan Hospital · NCT06300879Folfox+Irinotecan+Chemort In Esophageal Cancer
Phase 2 · 3 location(s) · Massachusetts General Hospital · NCT04656041Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis
NA · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT06162767A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable
Phase 1 · 4 location(s) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07059299QL1706 Combined With SOX Used in Theperioperative Treatment
Phase 1/Phase 2 · 1 location(s) · Xiangdong Cheng · NCT06766305Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Phase 3 · 1 location(s) · Chinese University of Hong Kong · NCT05264896HEARTS Trial for Thoracic Cancers
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT07132918Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Va
NA · 1 location(s) · Fujian Cancer Hospital · NCT07142122Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagog
Phase 2 · 18 location(s) · National Cancer Center, Japan · NCT07699939A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06623396A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
Phase 1 · 2 location(s) · JiaRay Group · NCT06783569XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05494060A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Phase 2 · 10 location(s) · Memorial Sloan Kettering Cancer Center · NCT06123338Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Canc
Phase 2 · 5 location(s) · Xijing Hospital · NCT06576921Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esopha
Phase N/A · 1 location(s) · P. Herzen Moscow Oncology Research Institute · NCT07441785Neoadjuvant Treatment Modalities in Esophageal Cancer
Phase 3 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT04821843PET-MRI Esophagus Feasibility Study
NA · 1 location(s) · University Health Network, Toronto · NCT05796102TAIC FOLFOX for Locally Advanced G/GEJA
Phase 2 · 1 location(s) · Guang'anmen Hospital of China Academy of Chinese Medical Sci · NCT07655024Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric J
Phase N/A · 1 location(s) · Semmelweis University · NCT06713993Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)
Phase 2 · 8 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT05177133Comprehensive Perioperative Program Based on Prehabilitation, Nutritional Intervention and Psychological Support for Pat
NA · 1 location(s) · Masaryk Memorial Cancer Institute · NCT07671625An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation
Phase 2 · 1 location(s) · National Cancer Center Hospital East · NCT07018570MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT02988921Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)
NA · 1 location(s) · Imperial College London · NCT05412758
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.